v3.24.1.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses    
Research and development expenses $ 27,455 $ 21,528
Selling, general and administrative expenses 6,477 6,154
Loss from operations (33,932) (27,683)
Gain/(loss) from the change in fair value of derivative liabilities 6,341 (2,195)
Financial investment income 2,337 3,254
Related party loan interest income 1,222 990
Interest expense (412) 0
Other (loss)/gain, net (229) 34
Loss before income taxes (24,673) (25,598)
Income tax expense 623 174
Net loss $ (25,296) $ (25,772)
Weighted-average number of shares outstanding – basic (in shares) 276,263 275,494
Weighted-average number of shares outstanding – diluted (in shares) 276,263 275,494
Net loss per share basic (in dollars per share) $ (0.09) $ (0.09)
Net loss per share diluted (in dollars per share) $ (0.09) $ (0.09)

Source